MAB962
Human CLC Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB962-Each-of-1 | In Stock | ₹ 57,068.52 |
MAB962 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 57,068.52
GST (18%): ₹ 10,272.334
Total Price: ₹ 67,340.854
Antigen
CLC
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
B-cell stimulating factor 3, B-cell stimulatory factor 3, BSF-3, BSF3BSF-3, cardiotrophin-like cytokine factor 1, CISS2, CLCF1, CLCNNT-1, CRLF1 associated cytokine-like factor 1, neurotrophin-1/B-cell stimulating factor-3, NNT-1, NNT1B-cell-stimulating factor 3, Novel neurotrophin-1, NR6
Host Species
Mouse
Purification Method
Protein A or G purified from hybridoma culture supernatant
Regulatory Status
RUO
Gene ID (Entrez)
23529
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype
IgG2b
Applications
Western Blot, Immunohistochemistry
Clone
138815
Dilution
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.
Q9UBD9
Gene Symbols
CLCF1
Immunogen
E. coli-derived recombinant human CLC Leu28-Phe225 Accession # Q9UBD9
Quantity
500 μg
Primary or Secondary
Primary
Test Specificity
Detects human CLC in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) CT-1, rhCNTF, rhIL-6, rhIL-11, rhLIF, or rhOSM is observed.
Target Species
Human
Form
Purified
Related Products
Description
- CLC Monoclonal specifically detects CLC in Human samples
- It is validated for Western Blot, Immunohistochemistry.
Compare Similar Items
Show Difference
Antigen: CLC
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: B-cell stimulating factor 3, B-cell stimulatory factor 3, BSF-3, BSF3BSF-3, cardiotrophin-like cytokine factor 1, CISS2, CLCF1, CLCNNT-1, CRLF1 associated cytokine-like factor 1, neurotrophin-1/B-cell stimulating factor-3, NNT-1, NNT1B-cell-stimulating factor 3, Novel neurotrophin-1, NR6
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 23529
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2b
Applications: Western Blot, Immunohistochemistry
Clone: 138815
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.: Q9UBD9
Gene Symbols: CLCF1
Immunogen: E. coli-derived recombinant human CLC Leu28-Phe225 Accession # Q9UBD9
Quantity: 500 μg
Primary or Secondary: Primary
Test Specificity: Detects human CLC in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) CT-1, rhCNTF, rhIL-6, rhIL-11, rhLIF, or rhOSM is observed.
Target Species: Human
Form: Purified
Antigen:
CLC
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
B-cell stimulating factor 3, B-cell stimulatory factor 3, BSF-3, BSF3BSF-3, cardiotrophin-like cytokine factor 1, CISS2, CLCF1, CLCNNT-1, CRLF1 associated cytokine-like factor 1, neurotrophin-1/B-cell stimulating factor-3, NNT-1, NNT1B-cell-stimulating factor 3, Novel neurotrophin-1, NR6
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
23529
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2b
Applications:
Western Blot, Immunohistochemistry
Clone:
138815
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.:
Q9UBD9
Gene Symbols:
CLCF1
Immunogen:
E. coli-derived recombinant human CLC Leu28-Phe225 Accession # Q9UBD9
Quantity:
500 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human CLC in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) CT-1, rhCNTF, rhIL-6, rhIL-11, rhLIF, or rhOSM is observed.
Target Species:
Human
Form:
Purified
Antigen: CLC
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias: B-cell stimulating factor 3, B-cell stimulatory factor 3, BSF-3, BSF3BSF-3, cardiotrophin-like cytokine factor 1, CISS2, CLCF1, CLCNNT-1, CRLF1 associated cytokine-like factor 1, neurotrophin-1/B-cell stimulating factor-3, NNT-1, NNT1B-cell-stimulating factor 3, Novel neurotrophin-1, NR6
Host Species: Mouse
Purification Method: Protein A or G purified from hybridoma culture supernatant
Regulatory Status: RUO
Gene ID (Entrez): 23529
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG2b
Applications: Western Blot, Immunohistochemistry
Clone: 138815
Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.: Q9UBD9
Gene Symbols: CLCF1
Immunogen: E. coli-derived recombinant human CLC Leu28-Phe225 Accession # Q9UBD9
Quantity: 25 μg
Primary or Secondary: Primary
Test Specificity: Detects human CLC in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) CT-1, rhCNTF, rhIL-6, rhIL-11, rhLIF, or rhOSM is observed.
Target Species: Human
Form: Purified
Antigen:
CLC
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias:
B-cell stimulating factor 3, B-cell stimulatory factor 3, BSF-3, BSF3BSF-3, cardiotrophin-like cytokine factor 1, CISS2, CLCF1, CLCNNT-1, CRLF1 associated cytokine-like factor 1, neurotrophin-1/B-cell stimulating factor-3, NNT-1, NNT1B-cell-stimulating factor 3, Novel neurotrophin-1, NR6
Host Species:
Mouse
Purification Method:
Protein A or G purified from hybridoma culture supernatant
Regulatory Status:
RUO
Gene ID (Entrez):
23529
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG2b
Applications:
Western Blot, Immunohistochemistry
Clone:
138815
Dilution:
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL
Gene Accession No.:
Q9UBD9
Gene Symbols:
CLCF1
Immunogen:
E. coli-derived recombinant human CLC Leu28-Phe225 Accession # Q9UBD9
Quantity:
25 μg
Primary or Secondary:
Primary
Test Specificity:
Detects human CLC in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) CT-1, rhCNTF, rhIL-6, rhIL-11, rhLIF, or rhOSM is observed.
Target Species:
Human
Form:
Purified
Antigen: Rituximab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Gene Alias: B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: __
Gene ID (Entrez): __
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA
Clone: 2260A
Dilution: Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Accession No.: __
Gene Symbols: __
Immunogen: Full-length Rituximab
Quantity: 100 μg
Primary or Secondary: Primary
Test Specificity: Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species: Multi-species
Form: Supernatant
Antigen:
Rituximab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Gene Alias:
B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
__
Gene ID (Entrez):
__
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA
Clone:
2260A
Dilution:
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Accession No.:
__
Gene Symbols:
__
Immunogen:
Full-length Rituximab
Quantity:
100 μg
Primary or Secondary:
Primary
Test Specificity:
Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species:
Multi-species
Form:
Supernatant
Antigen: Rituximab
Classification: Monoclonal
Conjugate: Unconjugated
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Gene Alias: B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Host Species: Rabbit
Purification Method: Protein A or G purified from cell culture supernatant
Regulatory Status: __
Gene ID (Entrez): __
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype: IgG
Applications: Western Blot, Flow Cytometry, ELISA
Clone: 2260A
Dilution: Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Accession No.: __
Gene Symbols: __
Immunogen: Full-length Rituximab
Quantity: 25 μg
Primary or Secondary: Primary
Test Specificity: Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species: Multi-species
Form: Supernatant
Antigen:
Rituximab
Classification:
Monoclonal
Conjugate:
Unconjugated
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Gene Alias:
B lymphocyte antigen CD20, B lymphocyte surface antigen B1, Bp35, CD20, LEU 16, LEU16, Membrane spanning 4 domains subfamily A member 1, MS4A1
Host Species:
Rabbit
Purification Method:
Protein A or G purified from cell culture supernatant
Regulatory Status:
__
Gene ID (Entrez):
__
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Isotype:
IgG
Applications:
Western Blot, Flow Cytometry, ELISA
Clone:
2260A
Dilution:
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, ELISA, Binding Inhibition 2.5 ug/mL
Gene Accession No.:
__
Gene Symbols:
__
Immunogen:
Full-length Rituximab
Quantity:
25 μg
Primary or Secondary:
Primary
Test Specificity:
Detects Rituximab in Western blots in direct ELISAs. 100% cross-reactivity with Tositumomab and Ibritumomab (95% or higher sequence identity with Rituximab) and no cross-reactivity with Cetuximab, Trastuzumab, Brentuximab, Gemtuzumab, Adalimumab, Solanezumab, Teprotumumab, and Aducanumab is observed.
Target Species:
Multi-species
Form:
Supernatant